( NYSE:NVRO )

News from Nevro Corp. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 07, 2017, 16:14 ET Nevro Reports Second Quarter 2017 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jul 26, 2017, 16:10 ET Nevro to Present at the Canaccord Genuity Growth Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jul 24, 2017, 16:09 ET Nevro to Report Operating Results for the Second Quarter 2017

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jul 05, 2017, 06:59 ET Nevro Announces Preliminary Unaudited Second Quarter 2017 Revenue and Business Update

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jun 28, 2017, 18:41 ET EY Announces Rami Elghandour, President and CEO of Nevro, as 2017 Entrepreneur Of The Year®

Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today...


Jun 15, 2017, 18:45 ET Neurosurgery Selects the SENZA-RCT 24-Month Outcomes Publication as the Top Pain Paper of the Year

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


May 30, 2017, 16:10 ET Nevro to Present at the William Blair Growth Stock Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


May 08, 2017, 16:10 ET Nevro Reports First Quarter 2017 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


May 02, 2017, 16:10 ET Nevro to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic...


Apr 24, 2017, 16:10 ET Nevro to Report Operating Results for the First Quarter 2017

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Feb 23, 2017, 16:10 ET Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Feb 09, 2017, 16:10 ET Nevro to Report Operating Results for the Fourth Quarter and Full Year 2016

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Dec 22, 2016, 16:10 ET Nevro to Present at the 35th Annual J.P. Morgan Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Dec 09, 2016, 17:22 ET Nevro Announces Filing of Lawsuit by Boston Scientific

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Nov 28, 2016, 18:25 ET Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Nov 15, 2016, 16:10 ET Nevro to Present at the 28th Annual Piper Jaffray Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Nov 07, 2016, 16:10 ET Nevro Reports Third Quarter 2016 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Oct 24, 2016, 16:15 ET Nevro to Report Operating Results for the Third Quarter 2016

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Sep 06, 2016, 07:30 ET Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10™ Therapy over Traditional Spinal Cord Stimulation for Chronic Pain

 Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic...


Aug 25, 2016, 16:10 ET Nevro to Present at Upcoming Investor Conferences

 Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic...


Aug 08, 2016, 16:10 ET Nevro Reports Second Quarter 2016 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jul 25, 2016, 16:36 ET Nevro to Report Operating Results for the Second Quarter 2016

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jun 13, 2016, 16:15 ET Nevro Announces Full Exercise of Over-Allotment Option and Closing of Public Offering of $172.5 Million Convertible Senior Notes

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jun 09, 2016, 16:15 ET Nevro to Present at the JMP Securities Life Sciences Conference

 Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic...


Jun 08, 2016, 00:54 ET Nevro Announces Pricing of Public Offering of $150 Million Convertible Senior Notes

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...